Cuellar et al. identified SETDB1 as a critical factor in cell viability and survival in AML, with SETDB1 depletion leading to upregulation of type I IFN pathway genes and interferon‐stimulated genes (ISGs), such as IFIT1‐3 and MDA5.16 This evidence concerns the gene SETDB1 and acute myeloid leukemia.